Lynside® Immunity Prebiotic is the first patented yeast-based prebiotic. Its complex structure is degraded only by a few fundamental bacteria species not usually targeted by other prebiotics.
A dynamic in-vitro gut model study shows a long-lasting fermentation of Lynside® Immunity Prebiotic in proximal and distal colons. This scenario challenges the current prebiotic side effects, as it requires a very low daily dosage and promotes a continuing prebiotic response with low gas production. It induces both an adapted metabolic activity and a modulation of the microbiota composition, depending on the host enterotype. Lynside® Immunity Prebiotic offers untapped opportunities for personalized and adapted micronutrition to design new products dedicated to immune health.
DISCOVER ALL OUR LATEST NEWS
Vitafoods Asia – Asia’s blockbuster nutraceutical event is back and Gnosis by Lesaffre is there to meet you
From 5th – 7th October 2022, Gnosis by Lesaffre will be present at Vitafoods Asia, in Bangkok, Thailand and will attract more than 21,000 participants from all over the region.
Gnosis by Lesaffre Proudly Sponsors FASEB Folate, B12 and One-Carbon Metabolism Conference Sharing Key Role of Innovative Quatrefolic®
In August at the FASEB Conference, Dr. Stacey Smith of Gnosis by Lesaffre highlighted the innovative active form of folate, Quatrefolic® and Adonat® Premium SAMe, to support improved human health.